|4Mar 28, 7:00 AM ET

Glickman Mark A 4

4 · TherapeuticsMD, Inc. · Filed Mar 28, 2022

Insider Transaction Report

Form 4
Period: 2022-03-23
Glickman Mark A
Chief Business Officer
Transactions
  • Award

    Restricted Stock Units

    2022-03-23+260,000260,000 total
    Exercise: $0.00Common Stock (260,000 underlying)
Footnotes (1)
  • [F1]Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest in three equal installments annually beginning March 23, 2023, becoming fully vested on March 23, 2025.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION